|
시장보고서
상품코드
2052365
암 단클론항체 시장 : 원료별, 용도별, 최종사용자별, 지역별Cancer Monoclonal Antibodies Market, By Source, By Application, By End User, By Geography |
||||||
암 단클론항체 시장은 2026년에 1,294억 달러로 추정되며, 2033년까지 3,614억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 15.8%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 1,294억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 15.80% | 2033년 시장 규모 예측: | 3,614억 달러 |
암 단클론항체란 암세포를 식별하고, 암세포에 결합하는 능력을 가진 인공적으로 만들어진 단백질을 말합니다. 이 항체는 정상 세포에 해를 끼치지 않고 인체 내 암세포를 식별하고 극복하기 위해 제약회사에 의해 상업적으로 개발되고 있습니다. 이들은 암세포 표면에서 발견되는 특정 분자에 결합하여 인체의 면역체계가 암세포를 선택적으로 인식하고 공격할 수 있도록 도와주는 역할을 합니다. 암 유병률의 증가, 새로운 항체 의약품으로 이어지는 지속적인 연구 개발, 암에 취약한 고령 인구의 증가로 인해 세계 항암제 시장은 최근 몇 년 동안 괄목할 만한 성장세를 보이고 있습니다.
시장 역학
세계 암 단클론항체 시장의 성장은 담배 소비 증가, 발암물질 노출, 생활습관 변화, 고령화 등의 요인으로 인한 전 세계 암 발병률 증가에 의해 주도되고 있습니다. 2022년 5월 기준 세계보건기구(WHO) 추산에 따르면, 2040년까지 암 신규 환자 수는 2,700만 명, 암으로 인한 사망자 수는 1,630만 명에 달할 것으로 예상하고 있습니다. 시장 성장을 이끄는 또 다른 큰 요인은 지속적인 연구개발을 통해 다양한 종류의 암에 대한 새로운 단클론항체 의약품 및 병용요법이 발견되어 환자의 예후가 개선되고 있다는 점입니다. 하지만, 단클론항체 의약품에 따른 고비용은 보급에 큰 제약이 되고 있습니다. 또한, 엄격한 규제 정책과 긴 제품 승인 절차도 문제점으로 지적되고 있습니다. 한편, 의료비 지출이 증가하고 있는 신흥국 시장에서는 큰 비즈니스 기회가 창출되고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 이 보고서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트도 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 암 단클론항체 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 암 단클론항체 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 암 단클론항체 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 암 단클론항체 시장 : 원료별, 2021-2033년
제5장 암 단클론항체 시장 : 용도별, 2021-2033년
제6장 암 단클론항체 시장 : 최종사용자별, 2021-2033년
제7장 세계의 암 단클론항체 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고문헌 및 조사 방법
KSM 26.06.11Cancer Monoclonal Antibodies Market is estimated to be valued at USD 129.40 Bn in 2026 and is expected to reach USD 361.40 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 129.40 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 15.80% | 2033 Value Projection: | USD 361.40 Bn |
Cancer monoclonal antibodies are artificially created proteins that have the capability to identify and bind themselves to cancer cells. These antibodies are commercially developed by pharmaceutical companies to identify and overcome cancer cells in the human body without harming normal cells. They work by attaching themselves to specific molecules found on cancer cell surfaces and helping the body's own immune system to recognize and attack those cancer cells selectively. The global cancer monoclonal antibodies market has witnessed tremendous growth in recent years due to the increasing prevalence of cancer, ongoing research, and development leading to novel antibody drugs and the growing geriatric population which is more prone to cancer.
Market Dynamics
The global cancer monoclonal antibodies market growth is driven by the rising incidence of cancer worldwide owing to factors like increasing tobacco consumption, exposure to carcinogenic substances, changing lifestyle patterns, and growing elderly population. in May 2022, as per the WHO estimates, cancer burden is expected to reach 27 million new cases and 16.3 million cancer deaths by 2040. Another major market growth driver is the ongoing research and development leading to the discovery of novel monoclonal antibody drugs and combination therapies for various cancer types which has improved patient outcomes. However, high costs associated with monoclonal antibody drugs acts as a major restraint for widespread adoption. Also, stringent regulatory policies and lengthy product approval process adds to the challenges. The market sees lucrative opportunities arising from emerging economies with growing healthcare expenditures.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cancer monoclonal antibodies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abnova Corporation, BioGenex, Bio-Rad Laboratories, Inc., AMSBIO, Elabscience Bionovation Inc., Fortis Life Sciences, Creative Diagnostics, Rockland Immunochemicals, Inc., GenScript, Leinco Technologies, Abcam Limited, and Sino Biological, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cancer monoclonal antibodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer monoclonal antibodies market
Market Segmentation
- By Source Insights (Revenue, USD Bn, 2021 - 2033)
- Human
- Chimeric
- Murine
- Humanized
- By Application Insights (Revenue, USD Bn, 2021 - 2033)
- Blood Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Liver Cancer
- Others
- By End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital
- Clinical and Diagnostic Laboratories
- Research Institutes
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abnova Corporation
- BioGenex
- Bio-Rad Laboratories, Inc.
- AMSBIO
- Elabscience Bionovation Inc.
- Fortis Life Sciences
- Creative Diagnostics
- Rockland Immunochemicals, Inc.
- GenScript
- Leinco Technologies
- Abcam Limited
- Sino Biological, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Cancer Monoclonal Antibodies Market, By Source
- Cancer Monoclonal Antibodies Market, By Application
- Cancer Monoclonal Antibodies Market, By End User
- Cancer Monoclonal Antibodies Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Market Trends
- Key Developments
4. Cancer Monoclonal Antibodies Market, By Source, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Human
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chimeric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Murine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Humanized
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Cancer Monoclonal Antibodies Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Blood Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Cancer Monoclonal Antibodies Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Clinical and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Cancer Monoclonal Antibodies Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioGenex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AMSBIO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elabscience Bionovation Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fortis Life Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Creative Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Rockland Immunochemicals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Leinco Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abcam Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sino Biological, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
